Healthcare | 06 May 2022 | Analysis
Is On-demand Healthcare Taking Off?
When the pandemic crisis struck, as a mode of business continuity, many Asia Pacific (APAC) countries accelera...Read more
Pharma | 06 May 2022 | Analysis
5 Transformative Merits of Blockchain in Pharma
Blockchain - an open, decentralised, secure, public ledger and the technology behind crypto currencies like bi...Read more
Australia | 23 May 2022 | News
Starpharma's nasal spray effective against influenza A & B virus
Australia-based Starpharma has announced that SPL7013, the antiviral agent in VIRALEZE nasal spray, achieved 9...Read more
India | 19 May 2022 | News
Dr. Reddy's signs multi-country deal for gastroenterology in India & select Emerging Markets
Indian firm Dr. Reddy’s Laboratories has entered into an exclusive partnership with South Korea-based HK...Read more
Japan | 27 April 2022 | News
University of Tokyo, Astellas further advance development of innovative medicines
The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaborati...Read more
Japan | 19 May 2022 | News
Japan's GHIT advances global fight against infectious diseases
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Japan-based Global Health Innovative...Read more
Singapore | 13 May 2022 | News
Singapore announces new collaborative project for cardiovascular disease research
The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and Bioin...Read more
Japan | 23 May 2022 | News
Japan sets new model case of personalised healthcare based on wearable tracking devices
Tohoku University- Tohoku Medical Megabank Organization, Daiichi Sankyo Company, Takeda Pharmaceutical Company...Read more
Singapore | 19 May 2022 | News
Singapore develops transparent medical masks for speech therapists
The Agency for Science, Technology and Research (A*STAR), Sengkang General Hospital (SKH), and local masks man...Read more
Korea | 23 May 2022 | News
Korean firm Hanmi FC to invest 10 billion KRW for building facilities for 'high-tech CDMOs'
South Korea-based Hanmi Fine Chemical, a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active...Read more
Japan | 12 May 2022 | News
Crown Bioscience to provide preclinical and translational services in Japan
US-based Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, have a...Read more
Taiwan | 10 May 2022 | News
Bora establishes leadership position in Taiwan's CDMO sector with new acquisition
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has recently anno...Read more
Oz BUDGET BOLSTERS HEALTHCARE
Circumstances have continued to evolve as the COVID-19 Omicron variant has added further pressure to Australia’s healthcare sector, as well as increasing supply chain disruptions, bringing about staff shortages and reducing household spending. With a Federal election due on May 21, 2022 to elect members of the 47th Parliament of Australia, Josh Frydenberg, Treasurer of the Commonwealth of Australia presented the Federal Budget on March 29. The Coalition Government led by Scott Morrison is investing in a stronger health system as part of its plan for a stronger future through a record $132 billion in 2022–23 Budget, increasing to $140 billion in 2025–26, with a total commitment of $537 billion over the next four years. This record funding will ensure Australians have access to improved healthcare, when and where they need it, helping them to lead healthier lives, with improved health outcomes and to provide ongoing protection against COVID-19.
For Feedback Email Us : communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
